The first cord blood bank in the British Isles was established in Belfast in June 1993. Cord blood (CB) is rich in haematopoietic progenitor cells and has been used successfully as a substitute for bone marrow transplants in over 200 patients world-wide. Most have received CB from a histocompatible sibling, but reports include several unrelated HLA matched transplants. In addition to the cryopreservation of 400 units of donated CB in the Cord Blood Bank, we have stored eight CB collections from siblings of children with leukaemia in Northern Ireland. A pilot study in collaboration with the maternity unit in the Mater Infirmorum Hospital confirmed the feasibility of a CB banking programme and highlighted many issues relating to Good Manufacturing Practice (GMP). The authors describe experience of collecting 824 units of CB over three years and discuss a few of the wider implications of this innovation in the management of patients requiring myeloablative therapy.
INTRODUCTION
Umbilical Cord Blood (CB) is a source of haematopoietic stem cells which can be used as an alternative to bone marrow for transplantation. I Since the first report ofa successful CB transplant2 more than 200 children and adults with congenital or malignant diseases have received histocompatible CB from a sibling or stored unrelated HLA-matched CB. The Belfast Cord Blood Bank is based within the Northern Ireland Blood Transfusion Service (NIBTS) and consists of dedicated sibling donations for specified patients and unrelated donations for general use.
SIBLING DONATIONS
There is general agreement among haematologists and oncologists that cord blood from a sibling must be cryopreserved if an older child in the family is known to suffer from a disease which is normally treated with bone marrow transplantation.3 Many CB transplants carried out to date have used sibling collections. We have received requests from the paediatric haematologist for collection of CB from siblings ofnine patients with leukaemia when their mothers have become pregnant. Such sibling collections can be arranged in any hospital where delivery is scheduled. The obstetrician in charge is contacted and at least two midwives are trained in the collection procedure, with emphasis on the importance of sterile techniques and accurate documentation. To date, nine sibling collections have been cryopreserved from eight pregnancies (one mother had twins). So far it has not been deemed clinically necessary to use any of the stored units for transplant.
UNRELATED DONATIONS: INFORMED CONSENT
Information is provided to pregnant women by midwives and obstetricians towards the end of pregnancy. In consenting to CB banking, the mother agrees that the collection will not be reserved for any member of her family. At antenatal clinics, mothers are given a leaflet which explains the Cord Blood Bank and the use of CB as an alternative to donated bone marrow in medical treatment. The obstetrician or midwife discusses the programme with the mother, The Ulster Medical Joutrnial answering any queries. The leaflet contains a consent form: the mother gives her written consent to the collection of CB post-partum and consents to provide blood samples for all mandatory tests. The mother is assured that blood is not taken from the baby.
COLLECTION OF CORD BLOOD
Normal obstetric practice is not altered in any way for purposes of CB collection. The obstetrician is in charge of the collection procedure and the actual collection is performed by midwives with the placenta in utero. Midwives are trained by a member of NIBTS staff. After delivery, the cord is clamped and cut, and using appropriate aseptic techniques the umbilical vein is punctured. We use standard blood collection sets incorporating a bag containing anticoagulant, sterile tubing and a needle which is used to pierce the umbilical vein; blood is allowed to drain into the bag under gravity. In addition to sterile collection of the CB, a small sample is milked from the cord into a tube for use as an archive serum sample. A venous sample is collected from the mother for microbiology tests. Midwives complete forms to provide the mother's details and those of the birth. Thorough documentation of the CB donation is meticulously carried out during collection and processing of samples. Unique barcode labels are affixed to all samples and to the CB pack. These labels are specific for each collection and are an integral part of the documentation system for the CB donations. Any labels that remain unused are returned to NIBTS with the collection.
PROCESSING OF CORD BLOOD COLLECTIONS
CB is transported each morning from maternity units to NIBTS under the strictly controlled conditions which we use for blood and blood products. At NIBTS all details are recorded and 3 ml CB is removed under sterile conditions from the blood pack using a needle and syringe. This sample is used for ABO and Rhesus grouping, HLA typing, bacterial cultures and nucleated cell counts. The remaining CB in the pack is mixed with an equal volume of cryodiluent prior to freezing. The cryodiluent consists of sterile dimethyl sulphoxide (DMSO) and albumin in a ratio of 1:4; this protects the integrity of the stem cells. DMSO is exothermic and care is taken to add chilled cryodiluent slowly to GB with continuous mixing. The final mixture for freezing is double the volume of the CB and contains DMSO at a concentration of 10%. The CB/cryodiluent mixture in a freezing bag is placed between metal plates and frozen in a controlled rate freezer to a temperature of -I 00°C. Subsequently, the frozen packs are transferred to liquid nitrogen tanks where they are stored in the vapour phase.
RESULTS
A total of 824 units of CB were collected, of which 186 are available for unrelated transplantation and the remaining collections are used for validation, quality assurance procedures and development of improved techniques for storage. There is a wide range in the volume collected (12.5 to 189ml) with a median of 72ml (Fig. 1) . The range in mononuclear cell (MNC) numbers was 0.3 to 18. 1 x 1 08/unit with a median MNC of 3.1 x 108/unit (Fig. 2) . Total nucleated cell numbers were also assessed: the range was 0.1 to 33 x 108/unit,with a median of 7.1 x 108/ unit (Fig. 3 ). 
